Dr. Vin Gupta: Blood clots from J&J vaccine ‘exceptionally rare’
04:22
Share this -
copied
Federal health authorities recommended that providers temporarily stop administering the Johnson & Johnson Covid-19 vaccine while they investigate a potential link to very rare blood clots. Six women between the ages of 18 and 48 developed blood clots after receiving the Johnson & Johnson vaccine and the clots are considered extremely rare. This is out of the more than 6.8 million people in the U.S. have received the Johnson & Johnson vaccine. Dr. Vin Gupta calls this "exceptionally rare, lower than the background rate ... It's to alert folks like myself and my colleagues that this is happening, extremely rarely, but this needs to be treated differently than what you treat a blood clot."April 14, 2021
UP NEXT
Legal expert: Expand the court with people who believe in secular government not theocracy
05:28
Sen. Klobuchar: If we can take back 2 Senate seats we can codify Roe v. Wade into law
11:03
Rep. Schiff: Without threat of mass resignations Trump would’ve gone through with this
10:53
Exclusive: New documentary footage shows Trump saying ‘stupid people’ refused to support Big Lie
06:17
‘Democrats, Pelosi were right to deny Jim Jordan place on Jan. 6 committee’ Democratic strategist says
09:54
Brittney Griner's wife: 'My push is for Biden Administration to make a deal for BG' with Russia